高级检索
当前位置: 首页 > 详情页

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303)

文献详情

编号/登记号:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究类型:
研究参与人:
研究单位: [1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd. [2]Chest hospital affiliated to Shanghai jiaotong university [3]Tianjin Medical University Cancer Hospital [4]Beijing Friendship Hospital, Capital Medical University,Beijing,Beijing,China [5]Capital Medical University, Beijing Chest Hospital,Beijing,Beijing,China [6]Chinese Academy of Medical Sciences Cancer Hospital,Beijing,Beijing,China [7]Peking Union Medical College Hospital,Beijing,Beijing,China [8]Chongqing Cancer Hospital,Chongqing,Chongqing,China [9]Xinqiao Hospital,Chongqing,Chongqing,China [10]Fujian Province Tumor Hospital,Fuzhou,Fujian,China [11]Gansu Province Tumor Hospital,Lanzhou,Gansu,China [12]Gansu Provincial People 's Hospital,Lanzhou,Gansu,China [13]Lanzhou Military General Hospital,Lanzhou,Gansu,China [14]First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China [15]First Affiliated Hospital of Shantou University Medical College,Shantou,Guangdong,China [16]Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China [17]Harbin medical university affiliated tumor hospita,Harbin,Heilongjiang,China [18]Henan Province Tumor Hospital,Luoyan,Henan,China [19]Hunan Province Tumor Hospital,Changsha,Hunan,China [20]Xiangya Hospital Central South University,Changsha,Hunan,China [21]Lianyungang First People ''s Hospital,Lianyungang,Jiangsu,China [22]Xuzhou Medical College Hospital,Xuzhou,Jiangsu,China [23]Jiangxi Province Tumor Hospital,Nanchang,Jiangxi,China [24]Second Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China [25]Jilin Province Tumor Hospital,Changchun,Jilin,China [26]Liaoning Provincial Tumor Hospital,Shenyang,Liaoning,China [27]Qilu Hospital,Shandong University,Jinan,Shandong,China [28]Shandong Province Tumor Hospital,Jinan,Shandong,China [29]Linyi City Tumor Hospita,Linyi,Shandong,China [30]Chest hospital affiliated to Shanghai jiaotong university,Shanghai,Shanghai,China,200000 [31]Cancer Hospital of Fudan University,Shanghai,Shanghai,China [32]Shanghai Changhai Hospital,Shanghai,Shanghai,China [33]Xinhua hospital affiliated to Shanghai jiaotong university,Shanghai,Shanghai,China [34]First Affiliated Hospital of Xi''an Jiaotong University,Xian,Shanxi,China [35]Tang Du Hospital,Xian,Shanxi,China [36]West China Hospital , Sichuan University,Chengdu,Sichuan,China [37]Sichuan Cancer Hospital,Chongqing,Sichuan,China [38]20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital .,Tianjin,Tianjin,China,300600 [39]Tianjin Medical University General Hospital,Tianjin,Tianjin,China [40]Yunnan Province Tumor Hospital,Kunming,Yunnan,China [41]The First Affiliated Hospital of Zhejiang University,Hangzhou,Zhejiang,China [42]The Second Affiliated Hospital of Zhejiang University,Hangzhou,Zhejiang,China [43]Zhejiang Province Tumor Hospital,Hangzhou,Zhejiang,China

关键词: anlotinib Cancer NSCLC Non-small Cell Lung Cancer

研究目的:
Evaluate the efficacy and safety of Anlotinib as the 3-line treatment of patients with advanced non-small lung cancer, with placebo control.

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号